About SPERO
Our Mission & Vision
Board of Directors
Management Team
Partners
Pipeline
SPR720
SPR206
Tebipenem HBr
Posters & Publications
PATIENTS
Nontuberculous Mycobacteria (NTM) Infections
Treating Antibiotic Resistance
Expanded Access
Careers
Current Job Listings
Life At Spero
Articles & Blogs
Benefits
Connect
Investor Relations
Press Releases
Events & Presentations
Stock Information
SEC Filings
Contact Us
ABOUT SPERO
Our Mission & Vision
Board of Directors
Management Team
Partners
PIPELINE
Our Pipeline
SPR720
SPR206
Tebipenem Hbr
Posters & Publications
PATIENTS
Nontuberculous Mycobacteria (NTM) Infections
Treating Antibiotic Resistance
Expanded Access
CAREERS
Current Job Listings
Life At Spero
Articles & Blogs
Benefits
CONNECT
Investor Relations
Press Releases
Events & Presentations
Stock Information
SEC Filings
Contact Us
Home
/
Article
/
Spero Article Post
The Anti-Infective Innovator Blog
Antibiotic Opportunity? Spero's Ankit Mahadevia on The Long Run Podcast
Antibiotic Opportunity? Spero's Ankit Mahadevia on The Long Run Podcast
The Anti-Infective Innovator Blog
Posted on
October 18, 2018
Written by Spero Therapeutics,
The Timmerman Report:
Sign up to receive news and announcements.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Recently Published
PASTEUR Act Reintroduced
Patients
Physicians Video Q & A
Pipeline
Explore Spero's Pipeline